We are a clinical-stage biotechnology startup company specializing in
CRISPR-based precision genome editing medicine. We focus on delivering affordable
one-and-done in-body “DNA surgery” for genetic diseases with unmet needs.
The Company's core areas of focus include novel Cas nuclease discovery and safe and efficient cargo delivery utilizing lipid nanoparticles (LNPs) and engineered protein delivery vehicles (PDVs).
Our visionary leaders bring decades of expertise in genome-editing therapy and business development, bringing innovation to affordable medical solutions. With deep scientific, clinical, business and strategic experience, they guide our mission to develop safe and precise CRISPR-based treatments.
We are building an expansive pipeline of cutting-edge in vivo genome-editing therapies that target ocular, metabolic, and rare diseases at their genetic roots. By editing genes directly in targeted organs and tissues in the body, we aim to cure diseases and improve quality of lives with safe, effective, and long-lasting medical solutions.
Are you passionate about science and making an impact? Join us.
We use Cookies to give you a better experience on our website. By continuing to browse the site without changing your privacy settings, you are consenting to our use of Cookies. For more information, please see our Privacy Policy Statement.
News Update
2025-05-16
GenEditBio Scientist Receives Excellence in Research Award at the 28th Annual Meeting of the American Society of Gene and Cell Therapy 2025
News Update
2025-06-06
GenEditBio Announces First Patient Dosed in Investigator-Initiated Trial of GEB-101, World’s First In Vivo CRISPR-Cas RNP-Based Genome Editing Investigational Therapy for TGFBI Corneal Dystrophy
News Update
2025-06-04
GenEditBio Co-Founder and Chairman Shares Expert Insights on Therapeutic Genome Editing in Exclusive PharmaBoardroom Interview: The Journey from Technology Innovator to Therapeutic Pioneer
Copyright © 2025 GenEditBio
Provide affordable precision DNA surgery for genetic diseases with unmet needs
Business Contact bd@geneditbio.com
Media Contact geb.media@geneditbio.com
HONG KONG Unit 101-102, Building 6W, 6 Science Park West Avenue, Hong Kong hkoffice@geneditbio.com
BEIJING 4/F, Building 29, Yard 18, Kechuang 13th St, VPark, Beijing